Skip to main content

Table 5 Cytotoxicity of L-OHP on OCUM-2MD3/L-OHP (μg/mL%, x ¯ ± S, 72 h).

From: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

Group

600

300

150

75

37.5

IC50

OCUM-2MD3

50.2 ± 1.8

40.6 ± 1.5

25.4 ± 2.7

19.2 ± 1.4

8.3 ± 1.7

522.3

OCUM-2MD3/L-OHP

38.4 ± 1.1*

24.7 ± 2.3*

17.5 ± 2.5*

9.8 ± 1.5*

5.6 ± 3.2*

1057.0

  1. *Compared with OCUM-2MD3 Group P < 0.05
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us